Skip to main content
. 2020 Oct 8;11:01329. doi: 10.3389/fphar.2020.01329

Figure 2.

Figure 2

Mean denosumab serum concentration-time profiles in the study. (A) Mean values; (B) log10 mean values; (C) ADA positive subjects (dotted line) and mean values (solid line) at QL1206 group; (D) ADA positive subjects (dotted line), and mean values (solid line) of the Xgeva® group.